What does Dr. Jan Bresseleers, cardiologie do?

Dr. Jan Bresseleers, cardiologie is a specialist medical practice in Aalter. Private Limited, started on 2 October 2020, 1 establishment.

What is the address of Dr. Jan Bresseleers, cardiologie?

The registered office of Dr. Jan Bresseleers, cardiologie is located at Heidestraat 8, 9880 Aalter.

Is Dr. Jan Bresseleers, cardiologie still active?

Yes. According to the CBE (27 September 2026) Dr. Jan Bresseleers, cardiologie is active, legal situation “Normale toestand”, started on 2 October 2020.

Is Dr. Jan Bresseleers, cardiologie registered on Peppol?

Yes, Dr. Jan Bresseleers, cardiologie is registered on the Peppol network with ID 0208:0755584864.

What is the enterprise number of Dr. Jan Bresseleers, cardiologie?

The enterprise number of Dr. Jan Bresseleers, cardiologie is BE0755584864.

When was Dr. Jan Bresseleers, cardiologie founded?

Dr. Jan Bresseleers, cardiologie was founded on 2 October 2020.

Who are the directors of Dr. Jan Bresseleers, cardiologie?

According to the 2025 annual accounts, the directors of Dr. Jan Bresseleers, cardiologie are: Jan Bresseleers.

Is Dr. Jan Bresseleers, cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 October 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Jan Bresseleers, cardiologie make in 2025?

Dr. Jan Bresseleers, cardiologie posted a profit after taxes of € 220,984 in financial year 2025.

What is the revenue of Dr. Jan Bresseleers, cardiologie?

As a small company, Dr. Jan Bresseleers, cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 304,607.

Dr. Jan Bresseleers, cardiologie (Private Limited)

Dossier Dr. Jan Bresseleers, cardiologie, printed on 27 September 2026 from databakkes.be/en/0755584864/dr-jan-bresseleers-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Jan Bresseleers, cardiologie from Aalter, company number BE0755584864, closed financial year 2025 with a result of € 220,984 after tax. For that financial year Dr. Jan Bresseleers, cardiologie recorded a gross margin of € 304,607 and equity of € 227,819. Compared with financial year 2024, the result moved from € 192,827 to € 220,984. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 19, 2026.

What it is worth Growing

€ 227,819

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 220,984

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 39,912

▼ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 192,000 paid out

87 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 23,464

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 18,955

▼ 30% vs 2024

€ 7,795 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 983

▼ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,878

▲ 80% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 189,454 Gross margin 2022: € 189,454 First fiscal year in the series	€ 225,677 Gross margin 2023: € 225,677 ▲ 19% vs 2022 (€ 189,454) Favourable step	€ 267,197 Gross margin 2024: € 267,197 ▲ 18% vs 2023 (€ 225,677) Favourable step	€ 304,607 Gross margin 2025: € 304,607 ▲ 14% vs 2024 (€ 267,197) Favourable step	▲ 14%
Profit after taxes	€ 141,689 Profit after taxes 2022: € 141,689 First fiscal year in the series	€ 162,669 Profit after taxes 2023: € 162,669 ▲ 15% vs 2022 (€ 141,689) Favourable step	€ 192,827 Profit after taxes 2024: € 192,827 ▲ 19% vs 2023 (€ 162,669) Favourable step	€ 220,984 Profit after taxes 2025: € 220,984 ▲ 15% vs 2024 (€ 192,827) Favourable step	▲ 15%
Equity	€ 198,281 Equity 2022: € 198,281 First fiscal year in the series	€ 208,009 Equity 2023: € 208,009 ▲ 5% vs 2022 (€ 198,281) Favourable step	€ 198,835 Equity 2024: € 198,835 ▼ 4% vs 2023 (€ 208,009) Unfavourable step	€ 227,819 Equity 2025: € 227,819 ▲ 15% vs 2024 (€ 198,835) Favourable step	▲ 15%
Total debts	€ 32,757 Total debts 2022: € 32,757 First fiscal year in the series	€ 37,924 Total debts 2023: € 37,924 ▲ 16% vs 2022 (€ 32,757) Unfavourable step	€ 33,478 Total debts 2024: € 33,478 ▼ 12% vs 2023 (€ 37,924) Favourable step	€ 28,390 Total debts 2025: € 28,390 ▼ 15% vs 2024 (€ 33,478) Favourable step	▼ 15%
Cash	€ 160,118 Cash 2022: € 160,118 First fiscal year in the series	€ 108,148 Cash 2023: € 108,148 ▼ 32% vs 2022 (€ 160,118) Unfavourable step	€ 63,382 Cash 2024: € 63,382 ▼ 41% vs 2023 (€ 108,148) Unfavourable step	€ 39,912 Cash 2025: € 39,912 ▼ 37% vs 2024 (€ 63,382) Unfavourable step	▼ 37%
Retained profit	€ 192,281 Retained profit 2022: € 192,281 First fiscal year in the series	€ 202,009 Retained profit 2023: € 202,009 ▲ 5% vs 2022 (€ 192,281) Favourable step	€ 192,835 Retained profit 2024: € 192,835 ▼ 5% vs 2023 (€ 202,009) Unfavourable step	€ 221,819 Retained profit 2025: € 221,819 ▲ 15% vs 2024 (€ 192,835) Favourable step	▲ 15%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 152,941 Dividend 2023: € 152,941 Unchanged (€ 0) Unchanged	€ 202,000 Dividend 2024: € 202,000 ▲ 32% vs 2023 (€ 152,941) Unchanged	€ 192,000 Dividend 2025: € 192,000 ▼ 5% vs 2024 (€ 202,000) Unchanged	▼ 5%
Bank debt	€ 10,273 Bank debt 2022: € 10,273 First fiscal year in the series	€ 34,890 Bank debt 2023: € 34,890 ▲ 240% vs 2022 (€ 10,273) Unfavourable step	€ 27,101 Bank debt 2024: € 27,101 ▼ 22% vs 2023 (€ 34,890) Favourable step	€ 18,955 Bank debt 2025: € 18,955 ▼ 30% vs 2024 (€ 27,101) Favourable step	▼ 30%
Balance sheet total	€ 231,038 Balance sheet total 2022: € 231,038 First fiscal year in the series	€ 245,932 Balance sheet total 2023: € 245,932 ▲ 6% vs 2022 (€ 231,038) Unchanged	€ 232,313 Balance sheet total 2024: € 232,313 ▼ 6% vs 2023 (€ 245,932) Unchanged	€ 256,209 Balance sheet total 2025: € 256,209 ▲ 10% vs 2024 (€ 232,313) Unchanged	▲ 10%

Key figures of Dr. Jan Bresseleers, cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Jan Bresseleers, cardiologie?

What happened at Dr. Jan Bresseleers, cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 19, 2026 New annual accounts for financial year 2025: profit of € 220,984 (▲ 15% vs 2024). Source: NBB ↗
Oct 2, 2020 New establishment in Aalter. KBO
2020 Jan Bresseleers became a director. NBB
Oct 2, 2020 Start of the company according to the CBE. KBO

In short

From € 141,689 profit in 2022 to € 220,984 profit in 2025.

Paid € 217,469 in corporate taxes since 2022.

Best year ever: 2025, with € 220,984 profit.

Paid out € 546,941 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Jan Bresseleers, cardiologie? We notify you, reason included.

Follow Dr. Jan Bresseleers, cardiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jan Bresseleers

Dr. Jan Bresseleers, cardiologie

Behind Dr. Jan Bresseleers, cardiologie is Jan Bresseleers.

See the full network in the app

Directors

According to the 2025 annual accounts

Jan Bresseleers

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Heidestraat 8

9880 Aalter

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0755.584.864
VAT number: BE 0755.584.864
Registered office: Heidestraat 8, 9880 Aalter
Names & denominations: Dr. Jan Bresseleers, cardiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 October 2020
Peppol: Active · Active since 28 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗